Xiaojing Du
Impact in
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications
Papers in
-
- Head and Neck Cancer Studies 19
- Oncology 16
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Hongxin Wang (13 shared papers)Huijuan Jing (11 shared papers)Xin Ying Huang (5 shared papers)Xin Cao (7 shared papers)Quanlin An (2 shared papers)Chaoyang Ma (2 shared papers)Ying Hao Sun (9 shared papers)Li Wang (7 shared papers)
- Journals
- 癌症：英文版 (3 papers)International Journal of Biological Macromolecules (3 papers)Frontiers in Oncology (2 papers)European Journal of Medicinal Chemistry (2 papers)JAMA (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xiaojing Du
97 papers receiving 3.6k citations
Xiaojing Du's Hit Papers
Peers
Comparison fields: 5 of 129
- Otorhinolaryngology 1.3k
- Molecular Medicine 174
- Oncology 519
- Cancer Research 158
- Pharmaceutical Science 83
Countries citing papers authored by Xiaojing Du
This map shows the geographic impact of Xiaojing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Du more than expected).
Fields of papers citing papers by Xiaojing Du
This network shows the impact of papers produced by Xiaojing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Du. The network helps show where Xiaojing Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojing Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma Hit paper breakdown → | 2019 | 694 |
| 2 | The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma Hit paper breakdown → | 2021 | 276 |
| 3 | Facile synthesis of pH-responsive sodium alginate/carboxymethyl chitosan hydrogel beads promoted by hydrogen bond Hit paper breakdown → | 2021 | 273 |
| 4 | Carbohydrate-based drugs launched during 2000−2021 Hit paper breakdown → | 2022 | 214 |
| 5 | 2018 | 177 | |
| 6 | Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma Hit paper breakdown → | 2022 | 121 |
| 7 | 2021 | 118 | |
| 8 | Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial Hit paper breakdown → | 2022 | 109 |
| 9 | 2014 | 106 | |
| 10 | 2022 | 106 | |
| 11 | 2020 | 90 | |
| 12 | 2021 | 69 | |
| 13 | 2021 | 59 | |
| 14 | 2018 | 58 | |
| 15 | 2015 | 54 | |
| 16 | Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma Hit paper breakdown → | 2024 | 54 |
| 17 | 2017 | 52 | |
| 18 | 2011 | 46 | |
| 19 | 2021 | 46 | |
| 20 | 2020 | 42 |
About Xiaojing Du
Xiaojing Du is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Molecular Medicine and Cancer Research, having authored 100 papers that have together received 3.7k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (19 papers), Cardiac Health and Mental Health (5 papers), Proteins in Food Systems (5 papers), Gastric Cancer Management and Outcomes (5 papers), Fibroblast Growth Factor Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Brain Metastases and Treatment (3 papers). The work is most often cited by research in Otorhinolaryngology (1.3k citations), Molecular Medicine (174 citations), Oncology (519 citations), Cancer Research (158 citations) and Pharmaceutical Science (83 citations). Xiaojing Du has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Hongxin Wang, Huijuan Jing, Xin Ying Huang, Xin Cao, Quanlin An, Chaoyang Ma, Ying Hao Sun, Li Wang, Jun Ma and Ling‐Long Tang. Their work appears in journals such as 癌症：英文版, International Journal of Biological Macromolecules, Frontiers in Oncology, European Journal of Medicinal Chemistry and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.